You just read:

Eisai and PIQUR Sign Landmark Collaboration Agreement to Investigate Halaven® (Eribulin) and PQR309 in Hard to Treat Form of Breast Cancer

News provided by

Eisai

17 Feb, 2016, 00:01 GMT